NCT01641848

Brief Summary

The primary objective of this study is to collect preoperative, operative and postoperative clinical assessments of patients that qualify for surgical implantation of the INBONE™ Total Ankle Prosthesis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2011

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

July 17, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

May 22, 2014

Status Verified

August 1, 2013

Enrollment Period

2 years

First QC Date

June 3, 2011

Last Update Submit

May 6, 2014

Conditions

Keywords

Total Ankle Arthroplasty

Outcome Measures

Primary Outcomes (1)

  • to measure the subject's pain, disability and activity level restrictions within the last week.

    The FFI, Foot Function Index is a validated self-administered scoring system designed to measure the subject's pain, disability and activity levels within the past week. Possible scores range from 0-100 with a lower score representing less pain, greater function and less restricted ambulation.

    to measure change from pre-op (baseline) at specified intervals up to 24 months post-op

Secondary Outcomes (1)

  • Radiographic Evaluation

    to measure change from pre-op to post-op at intervals up to 24 months postoperatively.

Study Arms (1)

Arthritic and injured ankles

EXPERIMENTAL

InBone TAA

Device: INBONE™ Total Ankle Prosthesis with Long Talar Stem

Interventions

INBONE™ Total Ankle Prosthesis with Long Talar Stem when used with a Calcaneal Stem

Arthritic and injured ankles

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has sufficient soft tissue and muscle strength to support stable, anatomic positioning and motion of arthroplasty components as determined by the investigator
  • Subject must have sufficient skin for wound coverage.
  • Subject demonstrates subtalar joint insufficiency as defined by any of the following:
  • (1)range of motion \<50 percent of the contralateral, non-diseased side (2)pain during physical examination of the subtalar joint (3)fusion
  • AND
  • Subject demonstrates tibio-talar joint insufficiency as defined by any of the following:
  • end stage arthritis as determined by the investigator on plain radiographs
  • pain during physical examination of the tibio-talar joint
  • fusion
  • non-union
  • failed Total Ankle Replacement 4.Subject has Body Mass Index (BMI) \< 40 5.Subject has sufficient calcaneal bone stock as determined by the investigator 6.Subject is able to or capable of providing consent to participate in the clinical investigation and has medical insurance to cover costs associated with their medical care or is willing to assume personal responsibility for costs 7.Subject agrees to comply with this protocol, including participating in required follow-up visits at the investigations site and completing study questionnaires

You may not qualify if:

  • Subject is skeletally immature and under 21 years of age
  • Subject has experienced local or systemic infection within the past twelve months
  • Subject has symptomatic ankle disease or has been treated operatively on the contralateral side
  • Subject has vascular and kidney insufficiencies
  • Subject is suspected to have neuropathy of the foot or ankle
  • Subject has impaired vascular circulation in the affected limb
  • Subject has skin condition that may impair wound healing
  • Subject has known allergy to cobalt, chromium, molybdenum, titanium, aluminum, vanadium, or nickel
  • Subjects on long term medications which may compromise bone stock (e.g. long term steroids, NSAIDS, etc., physicians discretion
  • Subject is unwilling or unable to comply with a rehabilitation program
  • Subject is known to be pregnant, a prisoner, mentally incompetent, and/or alcohol or drug abuser
  • Subject is currently participating in any investigational study not related to this study's preoperative and postoperative care.
  • Subject has rheumatoid arthritis (RA)
  • Subject has been diagnosed with osteoporosis as defined as a DXA t-score \>-2.5.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthopaedic Foot and Ankle Center

Columbus, Ohio, 43082, United States

Location

MeSH Terms

Conditions

Arthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Officials

  • Thomas Lee, M.D.

    Orthopedic Foot and Ankle Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2011

First Posted

July 17, 2012

Study Start

December 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

May 22, 2014

Record last verified: 2013-08

Locations